Year: 2025
Type: article
Abstract: This review summarizes how intratumoral microbiota influence tumor development and explores their potential as targets for drug delivery and immunotherapy enhancement.
Source: RSC Pharmaceutics
DOI: 10.1039/d5pm00045a
Authors: Huiling Liu, Zhonghui Luo, Fangzhen Luo, Xilian Wang, Hua Wei, Cui-Yun Yu
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4412818393
